Conference Call with Fortis Healthcare Management and Analysts on Q1FY26 Performance and Outlook. Listen to the full earnings transcript.
Healthcare Facilities company Fortis Healthcare announced Q1FY26 results Revenue: Rs 2,167 crore compared to Rs 1,859 crore during Q1FY25, change 16.6%. EBITDA: Rs 491 crore compared to Rs 343 crore during Q1FY25, change 43.2%. EBITDA Margin: 18.4% for Q1FY26. PAT: Rs 260 crore compared to Rs 166 crore during Q1FY25, change 56.8%. EPS: Rs 2.20 for Q1FY26. Ashutosh Raghuvanshi, MD & CEO, Fortis Healthcare said: “We have witnessed a healthy start to the financial year, as demonstrated in our Q1 earnings for both hospital and diagnostic businesses. The recently executed O&M; services agreement with Gleneagles India expands our geographic footprint and provides an opportunity to leverage our combined strengths to optimize operations and enhance efficiencies. The company also consummated the acquisition of Shrimann Superspecialty Hospital in Jalandhar, further strengthening our presence in Punjab region with approx. 1,000 beds.” Result PDF